Network information improves cancer outcome prediction

Briefings in Bioinformatics

Volumn 15, Issue 4, 2014, Pages 612-625

  Roy, Janine ^a   Winter, Christof ^b   Isik, Zerrin ^c   Schroeder, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c NONE

Author keywords

Cancer biomarker; Gene expression; Network based; Outcome prediction; PageRank

Indexed keywords

TUMOR MARKER;

ALGORITHM; DISEASE COURSE; HUMAN; NEOPLASM; PATHOPHYSIOLOGY;

ALGORITHMS; DISEASE PROGRESSION; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904717784     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbs083     Document Type: Article

References (69)

1. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415(6871):530-6.
2. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005;365(9458):488-92.
3. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 2006;103(15): 5923-8.
4. Wang Y, Klijn JGM, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365(9460):671-9.
5. Venet D, Dumont JE, Detours V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 2011;7(10):e1002240.
6. Klebanov L, Yakovlev A. How high is the level of technical noise in microarray data? Biol Direct 2007;2:9.
7. Shi L, Reid LH, Jones WD, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006;24(9):1151-61.
8. Dobbin KK, Beer DG, Meyerson M, et al. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res 2005;11(2 Pt 1):565-72.
9. Ideker T, Dutkowski J, Hood L. Boosting signal-to-noise in complex biology: prior knowledge is power. Cell 2011; 144(6):860-3.
10. Chuang HY, Lee E, Liu YT, et al. Network-based classification of breast cancer metastasis. Mol Syst Biol 2007;3:140.
11. Page L, Brin S, Motwani R, Winograd T. The Page Rank citation ranking: bringing order to the web. Technical Report, Stanford Digital Library Technologies Project, 1998.
12. Winter C, Kristiansen G, Kersting S, et al. Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol 2012;8(5):e1002511.
13. Fortney K, Jurisica I. Integrative computational biology for cancer research. Human Genet 2011;130:465-81.
14. Chowdhury SA, Koyuturk M. Identification of coordinately dysregulated subnetworks in complex phenotypes. Pac Symp Biocomput 2010;133-44.
15. Dao P, Colak R, Salari R, et al. Inferring cancer subnetwork markers using density-constrained biclustering. Bioinformatics 2010;26(18):i625-31.
16. Fortney K, Kotlyar M, Jurisica I. Inferring the functions of longevity genes with modular subnetwork biomarkers of Caenorhabditis elegans aging. Genome Biol 2010;11:R13.
17. Su J, Yoon BJ, Dougherty ER. Identification of diagnostic subnetwork markers for cancer in human protein-protein interaction network. BMC Bioinformatics 2010; 11(Suppl 6):S8.
18. Ulitsky I, Shamir R. Detecting pathways transcriptionally correlated with clinical parameters. Comput Syst Bioinformatics Conf 2008;7:249-58.
19. Dao P, Wang K, Collins C, et al. Optimally discriminative subnetwork markers predict response to chemotherapy. In: 19th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB 2011), 2011.
20. Hai DT, Lee W, Thuy HQ. A pageranking based method for identifying characteristic genes of a disease. In: IEEE International Conference on Networking, Sensing and Control (ICNSC2008), 2008;1496-9.
21. Johannes M, Brase JC, Fröhlich H, et al. Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients. Bioinformatics 2010;26:2136-44.
22. Morrison JL, Breitling R, Higham DJ, Gilbert DR. GeneRank: using search engine technology for the analysis of microarray experiments. BMC Bioinformatics 2005;6:233.
23. Nibbe RK, Koyutürk M, Chance MR. An integrative -omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput Biol 2010;6(1): e1000639.
24. Tarca AL, Draghici S, Khatri P, et al. A novel signaling pathway impact analysis. Bioinformatics 2009;25(1):75-82.
25. Davis NA, Crowe JEJ, Pajewski NM, McKinney BA. Surfing a genetic association interaction network to identify modulators of antibody response to smallpox vaccine. Genes Immun 2010;11(8):630-6.
26. Lee I, Blom UM, Wang PI, et al. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res 2011;1109-21.
27. Nirmala, Ancha B, Donald S, et al. A network-based approach to prioritize results from genome-wide association studies. PLoS One 2011;6(9):e24220.
28. Osmani GM, Rahman SM. Using Google's PageRank algorithm to identify important attributes of genes. In: Midwest Instruction and Computing Symposium (MICS 2007), 2007.
29. Chowdhury SA, Nibbe RK, Chance MR, Koyuturk M. Subnetwork state functions define dysregulated subnetworks in cancer. J Comput Biol 2011;18(3):263-81.
30. Ulitsky I, Krishnamurthy A, Karp RM, Shamir R. DEGAS: de novo discovery of dysregulated pathways in human diseases. PLoS One 2010;5(10):e13367.
31. Jones J, Otu H, Spentzos D, et al. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 2005;11(16):5730-9.
32. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13(3):361-6.
33. Lee JS, Leem SH, Lee SY, et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol 2010;28(16):2660-7.
34. Steidl C, Lee T, Shah SP, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010;362(10):875-85.
35. Bhojwani D, Kang H, Menezes RX, et al. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]. J Clin Oncol 2008;26(27):4376-84.
36. Bogunovic D, O'Neill DW, Belitskaya-Levy I, et al. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci USA 2009;106(48):20429-34.
37. Raponi M, Zhang Y, Yu J, et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 2006;66(15):7466-72.
38. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347(25):1999-2009.
39. Korkola JE, Houldsworth J, Feldman DR, et al. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol 2009;27:5240-7.
40. O'Donnell RK, Kupferman M, Wei SJ, et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 2005;24(7):1244-51.
41. Friedman DR, Weinberg JB, Barry WT, et al. A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia. Clin Cancer Res 2009;15(22):6947-55.
42. Landemaine T, Jackson A, Bellahcene A, et al. A six-gene signature predicting breast cancer lung metastasis. Cancer Res 2008;68(15):6092-9.
43. Nanni S, Priolo C, Grasselli A, et al. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer. Mol Cancer Res 2006;4(2):79-92.
44. Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010;115(5):1026-36.
45. Fernàndez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 2010;70(4):1408-18.
46. Frank O, Brors B, Fabarius A, et al. Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. Leukemia 2006;20(8):1400-7.
47. Smith JJ, Deane NG, Wu F, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 2010;138(3):958-68.
48. Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008;359(22):2313-23.
49. Mok SC, Bonome T, Vathipadiekal V, et al. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell 2009;16(6):521-32.
50. Dressman HK, Hans C, Bild A, et al. Gene expression profiles ofmultiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res 2006;12(3 Pt 1):819-26.
51. Murat A, Migliavacca E, Gorlia T, et al. Stem cell-related ''self-renewal'' signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008;26(18):3015-24.
52. Zhu CQ, Ding K, Strumpf D, et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected nonsmall-cell lung cancer. J Clin Oncol 2010;28(29):4417-24.
53. Prasad TSK, Goel R, Kandasamy K, et al. Human Protein Reference Database-2009 update. Nucleic Acids Res 2009; 37(Database issue):D767-72.
54. Matys V, Kel-Margoulis OV, Fricke E, et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006;34(Database issue):D108-10.
55. Srinivas PR, Verma M, Zhao Y, Srivastava S. Proteomics for cancer biomarker discovery. Clin Chem 2002;48(8):1160-9.
56. Stumpf MPH, Thorne T, de Silva E, et al. Estimating the size of the human interactome. Proc Natl Acad Sci USA 2008;105(19):6959-64.
57. Winnenburg R, Wachter T, Plake C, et al. Facts from text: can text mining help to scale-up high-quality manual curation of gene products with ontologies? Brief Bioinform 2008;9(6):466-78.
58. Venkatesan K, Rual JF, Vazquez A, et al. An empirical framework for binary interactome mapping. Nat Methods 2009;6(1):83-90.
59. Duda RO, Hart PE, Stork DG. Pattern Classification. 2nd edn. New York: John Wiley & Sons, 2001.
60. Lopez-Bergami P, Lau E, Ronai Z. Emerging roles of atf2 and the dynamic ap1 network in cancer. Nat Rev Cancer 2010;10(1):65-76.
61. Abdelrahim M, Samudio I, Smith R, III, et al. Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J Biol Chem 2002;277(32):28815-22.
62. Shi Q, Le X, Abbruzzese JL, et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res 2001;61(10):4143-54.
63. Hosoi Y, Watanabe T, Nakagawa K, et al. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 2004;25(2):461-8.
64. Chintharlapalli S, Papineni S, Ramaiah SK, et al. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 2007;67(6):2816-23.
65. Dutkowski J, Ideker T. Protein networks as logic functions in development and cancer. PLoS Comput Biol 2011;7(9): e1002180.
66. Chen L, Xuan J, Riggins RB, et al. Identifying cancer biomarkers by network-constrained support vector machines. BMC Syst Biol 2011;5:161.
67. Jordan IK, Marino-Ramirez L, Koonin EV. Evolutionary significance of gene expression divergence. Gene 2005;345(1):119-26.
68. Xing EP, Jordan MI, Karp RM. Feature selection for high-dimensional genomic microarray data. Proceedings of the Eighteenth International Conference on Machine Learning 2001. p. 601-8.
69. Jeffery IB, Higgins DG, Culhane AC. Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics 2006;7:359.